Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK's Vaccines Chief Slaoui To Follow Witty Out The Door

Executive Summary

One person definitely not lining up to take over from Sir Andrew Witty when he retires from GlaxoSmithKline PLC in March 2017 is its vaccines chief and former head of R&D Dr. Moncef Slaoui. He is to retire from the company in June 2017.


Related Content

More Change At GSK's Top, With Vaccines Chief Luc Debruyne Set To Say 'Adieu'
Finance Watch: Former GSK CEO Witty, R&D Head Slaoui Join VC Firms
GSK Files Blockbuster Hopeful Shingrix With FDA
GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy
GSK And Google To Invest £540m In UK-Headquartered Bioelectronics JV
Strong 2Q And Fresh UK Investment Signal Few Brexit Blues at GSK
2Q Preview: GSK, Bayer, Celgene, Amgen, AZ, BMS, Sanofi, Merck, Abbvie
Witty Succumbs To Pressure: GSK Starts Formal Search For New CEO


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts